FindTrial
Sign In

Comparing Minoxidil vs a Redensyl- based formula, Both combined with PRP therapy, for treating Male pattern baldness in men (18-55years) at a Kelambakkam hospital.

A COMPARATIVE STUDY OF TOPICAL 5 PERCENT MINOXIDIL WITH PLATELET RICH PLASMA THERAPY VERSUS TOPICAL REDENSYL, CAPIXYL AND PROCAPIL COMBINATION WITH PLATELET RICH PLASMA THERAPY IN THE TREATMENT OF ANDROGENETIC ALOPECIA IN MEN AGED 18-55 YEARS AT A TERTIARY HEALTH CARE CENTRE IN KELAMBAKKAM - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088077
Enrollment
50
Registered
2025-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L649- Androgenic alopecia, unspecified

Interventions

Intervention1: Topical Redensyl, Capixyl, Procapil combination with platelet rich plasma: Patients will receive PRP therapy once every 4 weeks (total-6 sessions) with topical medications every-day. PR

Sponsors

Dr J Mirudula Josena
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Androgenetic alopecia. Patients who have Grade II-V AGA (According to Norwood-Hamilton Classification)

Exclusion criteria

Exclusion criteria: Patients with dermatological diseases other than AGA on their head skin. Patients with endocrine disorders, metabolic disorders, platelet disorders, hypertension, and cardiovascular problems

Design outcomes

Primary

MeasureTime frame
To compare the safety and effectiveness of an alternative treatment, Redensyl, Capixyl, and Procapil (RCP) with PRP and commonly used Minoxidil 5 Percent solution with PRP in adult male patients suffering from Androgenetic Alopecia (AGA).Timepoint: Day 0, 4th week, 8th week, 12th week, 16th week, 20th week and 24th week—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDr Gopalakrishnan K

Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education

gopukris83@gmail.com044-47428101

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026